
We’re proud to announce that the Clinical Trial Risk Tool has been selected as a winner of the Plotly Dash Example Apps Challenge (2023), out of 25 amazing apps submitted by the community!
You can try the tool at clinicaltrialrisk.org.
Natural language processing
Funded by the Bill and Melinda Gates Foundation, this app uses natural language processing, Plotly Dash, and the spaCy and Scikit-Learn libraries to calculate the risk of a clinical trial failing to deliver informative results. It reads the trial protocol and identifies key features from the text which are fed into a risk model.
Thomas Wood will be presenting the tool in a webinar on 7 June 2023 which you can book here.
Thank you to all #PlotlyCommunity members who participated in the recent #Dash Example Apps Challenge, and congratulations to the winning submissions!
— Plotly (@plotlygraphs) May 22, 2023
🥇 Clinical Trial Risk Dash App by Thomas Wood
🥈 SARIMA Tuner by Gabriele Albini
🥉 Product Environmental Report Dash App by…
Meanwhile, an article describing the tool has been published at: Wood TA and McNair D. Clinical Trial Risk Tool: software application using natural language processing to identify the risk of trial uninformativeness. Gates Open Res 2023, 7:56 (https://doi.org/10.12688/gatesopenres.14416.1).
Download the pitch deck for the Clinical Trial Risk Tool
If you would like to cite the tool alone, you can cite:
Wood TA and McNair D. Clinical Trial Risk Tool: software application using natural language processing to identify the risk of trial uninformativeness. Gates Open Res 2023, 7:56 doi: 10.12688/gatesopenres.14416.1.
A BibTeX entry for LaTeX users is
@article{Wood_2023,
doi = {10.12688/gatesopenres.14416.1},
url = {https://doi.org/10.12688%2Fgatesopenres.14416.1},
year = 2023,
month = {apr},
publisher = {F1000 Research Ltd},
volume = {7},
pages = {56},
author = {Thomas A Wood and Douglas McNair},
title = {Clinical Trial Risk Tool: software application using natural language processing to identify the risk of trial uninformativeness},
journal = {Gates Open Research}
}
Looking for experts in Natural Language Processing? Post your job openings with us and find your ideal candidate today!
Post a Job
Thomas Wood presents the Clinical Trial Risk Tool before the November meeting of the Clinical AI Interest Group at Alan Turing Institute The Clinical AI Interest group is a community of health professionals from a broad range of backgrounds with an interest in Clinical AI, organised by the Alan Turing Institute.

Fast Data Science will appear at Ireland’s Expert Witness Conference on 20 May 2026 in Dublin On 20 May 2026, La Touche Training is running the Expert Witness Conference 2026, at the Radisson Blu Hotel, Golden Lane, Dublin 8, Ireland. This is a full-day event combining practical workshops and interactive sessions, aimed at expert witnesses and legal professionals who want to enhance their expertise. The agenda covers critical topics like recent developments in case law, guidance on report writing, and techniques for handling cross-examination.
Guest post by Alex Nikic In the past few years, Generative AI technology has advanced rapidly, and businesses are increasingly adopting it for a variety of tasks. While GenAI excels at tasks such as document summarisation, question answering, and content generation, it lacks the ability to provide reliable forecasts for future events. GenAI models are not designed for forecasting, and along with the tendancy to hallucinate information, the output of these models should not be trusted when planning key business decisions. For more details, a previous article on our blog explores in-depth the trade-offs of GenAI vs Traditional Machine Learning approaches.
What we can do for you